Memorial Sloan-Kettering Cancer Center's CancerSmart lectures feature informative discussions on the most up-to-date issues on cancer and cancer-related topics. Watch videos of recent CancerSmart lectures.
Dr. Max Gomez interviews Larry Norton, Deputy Physician-in-Chief for Breast Cancer Programs at Memorial Sloan-Kettering Cancer Center, about the latest developments in detecting and treating breast cancer.
Kenneth Offit, Chief of Memorial Sloan-Kettering's Clinical Genetics Service, discusses which tests should be used — or avoided — to guide your efforts to act on your familial risk for cancer of the colon or breast.
Experts from Memorial Sloan-Kettering Cancer Center discuss the latest approaches to early detection, screening, and treatment for women with cervical cancer.
Clifford Hudis, Chief of the Breast Cancer Medicine Service at Memorial Sloan-Kettering, provides an overview of breast cancer epidemiology, risk factors, treatment, as well as an update on promising breast cancer research studies.
A study has shown that a new drug for melanoma decreased the risk of death by 63 percent for people with advanced disease. The drug, an oral medical called vemurafenib, works by targeting and silencing a particular gene mutation associated with melanoma. Another study revealed that the FDA-approved ipilimumab (Yervoy™) bolsters the body’s immune system in fighting advanced melanoma. This therapy could extend life when combined with traditional chemotherapy.
Cancer survival is the “good news” in oncology, but survivors face many challenges in adjusting to life after cancer treatment, say experts from Memorial Sloan-Kettering Cancer Center.